Advertisement
Screener

G1 THERAPEUTICS, INC. Financing Cash Flow

G1 THERAPEUTICS, INC. Financing Cash Flow

G1 THERAPEUTICS, INC. reported Financing Cash Flow of -$8.49 million for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.

Discontinued › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2024-08-08

  • G1 THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2024-06-30 was $232.00K.
  • G1 THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2024-03-31 was -$8.72M.
  • G1 THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2023-12-31 was $34.00K, a 99.94% decline year-over-year.
  • G1 THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2023-09-30 was $22.00K, a 82.68% decline year-over-year.
  • G1 THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2023 was -$26.91M, a 151.27% decline from fiscal 2022.
  • G1 THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2022 was $52.49M, a 64.01% decline from fiscal 2021.
  • G1 THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2021 was $145.86M, a 572.55% increase from fiscal 2020.
  • G1 THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2020 was $21.69M, a 701.77% increase from fiscal 2019.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 month
2024-06-30$232.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$8.49M
10-Q · filed 2024-08-08
-$8.46M
derived: sum of 3 quarters · filed 2024-08-08
-$8.43M
derived: sum of 4 quarters · filed 2024-08-08
2024-03-31-$8.72M
10-Q · filed 2024-05-01
-$8.69M
derived: sum of 2 quarters · filed 2024-05-01
-$8.67M
derived: sum of 3 quarters · filed 2024-05-01
-$35.42M
derived: sum of 4 quarters · filed 2024-08-08
2023-12-31$34.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$56.00K
derived: sum of 2 quarters · filed 2024-02-28
-$26.70M
derived: sum of 3 quarters · filed 2024-08-08
-$26.91M
10-K · filed 2024-02-28
2023-09-30$22.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01
-$26.73M
derived: sum of 2 quarters · filed 2024-08-08
-$26.95M
10-Q · filed 2023-11-01
$25.40M
derived: sum of 4 quarters · filed 2024-08-08
2023-06-30-$26.75M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$26.97M
10-Q · filed 2024-08-08
$25.38M
derived: sum of 3 quarters · filed 2024-08-08
$25.51M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$214.00K
10-Q · filed 2024-05-01
$52.14M
derived: sum of 2 quarters · filed 2024-05-01
$52.26M
derived: sum of 3 quarters · filed 2024-05-01
$52.26M
derived: sum of 4 quarters · filed 2024-05-01
2022-12-31$52.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$52.48M
derived: sum of 2 quarters · filed 2024-02-28
$52.48M
derived: sum of 3 quarters · filed 2024-02-28
$52.49M
10-K · filed 2024-02-28
2022-09-30$127.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01
$127.00K
derived: sum of 2 quarters · filed 2023-11-01
$145.00K
10-Q · filed 2023-11-01
$43.90M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02
$18.00K
10-Q · filed 2023-08-02
$43.77M
derived: sum of 3 quarters · filed 2024-02-28
$45.86M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31$18.00K
10-Q · filed 2023-05-03
$43.77M
derived: sum of 2 quarters · filed 2024-02-28
$45.86M
derived: sum of 3 quarters · filed 2024-02-28
$47.34M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31$43.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$45.84M
derived: sum of 2 quarters · filed 2024-02-28
$47.32M
derived: sum of 3 quarters · filed 2024-02-28
$145.86M
10-K · filed 2024-02-28
2021-09-30$2.08M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02
$3.56M
derived: sum of 2 quarters · filed 2022-11-02
$102.11M
10-Q · filed 2022-11-02
$102.58M
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30$1.48M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03
$100.02M
10-Q · filed 2022-08-03
$100.50M
derived: sum of 3 quarters · filed 2023-03-01
$100.78M
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31$98.54M
10-Q · filed 2022-05-04
$99.01M
derived: sum of 2 quarters · filed 2023-03-01
$99.30M
derived: sum of 3 quarters · filed 2023-03-01
$120.01M
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31$472.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$756.00K
derived: sum of 2 quarters · filed 2023-03-01
$21.47M
derived: sum of 3 quarters · filed 2023-03-01
$21.69M
10-K · filed 2023-03-01
2020-09-30$284.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03
$21.00M
derived: sum of 2 quarters · filed 2021-11-03
$21.22M
10-Q · filed 2021-11-03
$21.60M
derived: sum of 4 quarters · filed 2022-02-23
2020-06-30$20.71M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04
$20.93M
10-Q · filed 2021-08-04
$21.32M
derived: sum of 3 quarters · filed 2022-02-23
$22.69M
derived: sum of 4 quarters · filed 2022-02-23
2020-03-31$219.00K
10-Q · filed 2021-05-05
$605.00K
derived: sum of 2 quarters · filed 2022-02-23
$1.98M
derived: sum of 3 quarters · filed 2022-02-23
$2.65M
derived: sum of 4 quarters · filed 2022-02-23
2019-12-31$386.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23
$1.76M
derived: sum of 2 quarters · filed 2022-02-23
$2.44M
derived: sum of 3 quarters · filed 2022-02-23
$2.71M
10-K · filed 2022-02-23
2019-09-30$1.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04
$2.05M
derived: sum of 2 quarters · filed 2020-11-04
$2.32M
10-Q · filed 2020-11-04
$2.42M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30$678.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$947.00K
10-Q · filed 2020-08-05
$1.05M
derived: sum of 3 quarters · filed 2021-02-24
$220.57M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31$269.00K
10-Q · filed 2020-05-06
$374.00K
derived: sum of 2 quarters · filed 2021-02-24
$219.90M
derived: sum of 3 quarters · filed 2021-02-24
$232.01M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31$105.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$219.63M
derived: sum of 2 quarters · filed 2021-02-24
$231.74M
derived: sum of 3 quarters · filed 2021-02-24
$340.49M
10-K · filed 2021-02-24
2018-09-30$219.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
$231.63M
derived: sum of 2 quarters · filed 2019-11-05
$340.39M
10-Q · filed 2019-11-05
$340.59M
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30$12.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$120.87M
10-Q · filed 2019-08-07
$121.07M
derived: sum of 3 quarters · filed 2020-02-26
$120.77M
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31$108.75M
10-Q · filed 2019-05-09
$108.96M
derived: sum of 2 quarters · filed 2020-02-26
$108.65M
derived: sum of 3 quarters · filed 2020-02-26
2017-12-31$202.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
-$101.00K
derived: sum of 2 quarters · filed 2020-02-26
$107.32M
10-K · filed 2020-02-26
2017-09-30-$303.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$107.12M
10-Q · filed 2018-11-07
2017-06-30$107.42M
10-Q · filed 2018-08-08
2016-12-31$49.76M
10-K · filed 2019-02-28